| Functional delivery of viral miRNAs via exosomes DM Pegtel, K Cosmopoulos, DA Thorley-Lawson, MAJ van Eijndhoven, ... Proceedings of the National Academy of Sciences 107 (14), 6328-6333, 2010 | 1859 | 2010 |
| Persistence of the Epstein–Barr virus and the origins of associated lymphomas DA Thorley-Lawson, A Gross New England Journal of Medicine 350 (13), 1328-1337, 2004 | 1274 | 2004 |
| Epstein-Barr virus: exploiting the immune system DA Thorley-Lawson Nature Reviews Immunology 1 (1), 75, 2001 | 1238 | 2001 |
| EBV persistence in memory B cells in vivo GJ Babcock, LL Decker, M Volk, DA Thorley-Lawson Immunity 9 (3), 395-404, 1998 | 1077 | 1998 |
| Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo LL Laichalk, DA Thorley-Lawson Journal of virology 79 (2), 1296-1307, 2005 | 658 | 2005 |
| The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell GJ Babcock, D Hochberg, DA Thorley-Lawson Immunity 13 (4), 497-506, 2000 | 614 | 2000 |
| A novel form of Epstein-Barr virus latency in normal B cells in vivo EM Miyashita, B Yang, KMC Lam, DH Crawford, DA Thorley-Lawson Cell 80 (4), 593-601, 1995 | 420 | 1995 |
| Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. EM Miyashita, B Yang, GJ Babcock, DA Thorley-Lawson Journal of virology 71 (7), 4882-4891, 1997 | 416 | 1997 |
| Epstein-Barr virus–infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients GJ Babcock, LL Decker, RB Freeman, DA Thorley-Lawson Journal of Experimental Medicine 190 (4), 567-576, 1999 | 403 | 1999 |
| The curious case of the tumour virus: 50 years of Burkitt's lymphoma DA Thorley-Lawson, MJ Allday Nature Reviews Microbiology 6 (12), 913, 2008 | 378 | 2008 |
| Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo D Hochberg, JM Middeldorp, M Catalina, JL Sullivan, K Luzuriaga, ... Proceedings of the National Academy of Sciences 101 (1), 239-244, 2004 | 366 | 2004 |
| EBV persistence—introducing the virus DA Thorley-Lawson Epstein Barr Virus Volume 1, 151-209, 2015 | 355 | 2015 |
| Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen N Sutkowski, B Conrad, DA Thorley-Lawson, BT Huber Immunity 15 (4), 579-589, 2001 | 340 | 2001 |
| The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output V Hadinoto, M Shapiro, CC Sun, DA Thorley-Lawson PLoS pathogens 5 (7), e1000496, 2009 | 326 | 2009 |
| Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. KP Mann, D Staunton, DA Thorley-Lawson Journal of virology 55 (3), 710-720, 1985 | 317 | 1985 |
| The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. LL Decker, P Shankar, G Khan, RB Freeman, BJ Dezube, J Lieberman, ... Journal of Experimental Medicine 184 (1), 283-288, 1996 | 301 | 1996 |
| EBV and systemic lupus erythematosus: a new perspective AJ Gross, D Hochberg, WM Rand, DA Thorley-Lawson The Journal of Immunology 174 (11), 6599-6607, 2005 | 297 | 2005 |
| The pathogenesis of Epstein–Barr virus persistent infection DA Thorley-Lawson, JB Hawkins, SI Tracy, M Shapiro Current opinion in virology 3 (3), 227-232, 2013 | 289 | 2013 |
| Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity DA Thorley-Lawson, K Geilinger Proceedings of the National Academy of Sciences 77 (9), 5307-5311, 1980 | 279 | 1980 |
| Is EBV persistence in vivo a model for B cell homeostasis? G Khan, EM Miyashita, B Yang, GJ Babcock, DA Thorley-Lawson Immunity 5 (2), 173-179, 1996 | 269 | 1996 |
